EcoDrugPlus

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPMAG00000010426
Gene Symbol: CYSLTR1
1 Cross references
244 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPMAG00000001210
Gene Symbol: CYSLTR1
1 Cross references
54 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPMAG00000009916
Gene Symbol: CYSLTR1
1 Cross references
244 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSPMAG00000004431
Gene Symbol: DGAT1A
1 Cross references
263 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSPMAG00000007116
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSPMAG00000010421
Gene Symbol: DRD1B
1 Cross references
310 Possible Orthologues:

Dopamine Receptor D2b

Ensembl ID : ENSPMAG00000000994
Gene Symbol: DRD2B
1 Cross references
304 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSPMAG00000009618
Gene Symbol: DRD4B
1 Cross references
309 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSPMAG00000004401
Gene Symbol: EZH2
1 Cross references
240 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPMAG00000001270
Gene Symbol: XPO1
2 Cross references
150 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSPMAG00000000649
Gene Symbol: FDPS
1 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSPMAG00000007639
Gene Symbol: FDFT1
1 Cross references
221 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).